Drug recall · March 27, 2013
ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets recall
Why: Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton; NDC 52544-981-28
- Lots / codes
Lot #s: 401536AA/401536A; 401537AA/401537/A; 401538AA/401538/A; 406985AA/406985A; 432058AA/432058A; 512685AA/512685A
- Quantity
- 136,720 cartons
- Company
- Watson Laboratories Inc, Corona, CA
- Distribution
- Nationwide
- Initiated
- February 13, 2013 · Voluntary: Firm initiated
- Classified
- March 19, 2013
- Reported
- March 27, 2013
- Ended
- January 31, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.